Skip to content

Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device

Evaluation of the Performance and Use of GlucoTrack Model DF-F Non-Invasive Glucose Monitoring Device.

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00889668
Acronym
CR-01-001
Enrollment
180
Registered
2009-04-29
Start date
2009-05-31
Completion date
2012-10-31
Last updated
2012-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Keywords

Glucose monitoring, GlucoTrack, Self glucose monitoring

Brief summary

Diabetes is a leading cause of death in the Western World with medical costs increasing annually. There is no cure for diabetes, and blood glucose monitoring is a key component in diabetes treatment and management. Self-monitoring of blood glucose levels is essential to the self-management of diabetes and has become widespread over the past decade. Blood glucose determinations are currently done by invasive methods (finger tip pricking), followed by measuring the blood drop characteristics. The purpose of this trail is to demonstrate the performance and use of GlucoTrack device in measuring blood glucose levels. The rationale for development of the device is to improve the patient's quality of life by providing a device that is easily used and provides a painless measurement method, thereby leading to higher compliance, and to better managed diabetes

Detailed description

See Brief summary

Interventions

comparison of different glucose monitoring devices

Sponsors

Integrity Applications Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type 1or 2 Diabetes * Anatomically suitable earlobe

Exclusion criteria

* Subjects requiring dialysis * Any conditions that may hamper good contact between the PEC and the earlobe * Pregnancy * Nursing mothers

Design outcomes

Primary

MeasureTime frame
Clarke Error Gridone year

Secondary

MeasureTime frameDescription
User Satisfactionone yearBased on user questionnaire, user satisfection will be analyzed

Countries

Israel

Contacts

Primary ContactSagit Saadon, MA
+972 (8) 675-7878

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026